DRREDDY's weekly performance was disappointing, with a return of -2.98% and a Sharpe Ratio of -1.51, indicating poor risk-adjusted returns. The stock's volatility was moderate at 7.91%, but its Max Drawdown of -2.98% suggests a significant decline in value. Compared to its peers, DRREDDY underperformed, with only SUNPHARMA posting a lower return. The stock's risk profile was relatively high this week.

[Volatility: 7.91%]